Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials

Author:

Eugenia-Toledo-Romaní María,Verdecia-Sánchez Leslyhana,Rodríguez-González Meiby,Rodríguez-Noda Laura,Valenzuela-Silva Carmen,Paredes-Moreno Beatriz,Sánchez-Ramírez Belinda,Pérez-Nicado Rocmira,González-Mugica Raul,Hernández-García Tays,Bergado-Baez Gretchen,Pi-Estopiñán Franciscary,Cruz-Sui Otto,Fraga-Quintero Anitza,García-Montero Majela,Palenzuela-Díaz Ariel,Baró-Román Gerardo,Mendoza-Hernández Ivis,Fernandez-Castillo Sonsire,Climent-Ruiz Yanet,Santana-Mederos Darielys,Ramírez Gonzalez Ubel,García-Vega Yanelda,Pérez-Massón Beatriz,Guang-Wu-Chen ,Boggiano-Ayo Tammy,Ojito-Magaz Eduardo,Rivera Daniel G.,Valdés-Balbín Yury,García-Rivera Dagmar,Vérez-Bencomo Vicente,Gómez-Maceo Yanet,Reyes-Matienzo Radamet,Manuel Coviella-Artime José,Morffi-Cinta Irania,Martínez-Pérez Marisel,Castillo-Quintana Ismavy,Garcés-Hechavarría Aniurka,Valera-Fernández Rodrigo,Martínez-Bedoya Dayle,Garrido-Arteaga Raine,Cardoso-SanJorge Félix,Quintero Moreno Lauren,Ontivero-Pino Ivis,Teresa Pérez-Guevara María,Morales-García Marilin,Noa-Romero Enrique,Orosa-Vázquez Ivette,Díaz-Hernández Marianniz,Rojas Gertrudis,Tundidor Yaima,García-López Elena,Muñoz-Morejon Yaima,Galano-Frutos Evelyn,Rodríguez-Alvarez Julián,Arteaga Amaylid,Medina Nápoles Maite,Espi Ávila Jennifer,Fontanies Fernández Marcos

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference49 articles.

1. WHO Coronavirus (COVID-19) Dashboard, https://covid19.who.int/ (Consulted October 20, 2021).

2. Guidance for Industry: Development and Licensure of Vaccines to Prevent COVID-19, USFDA, June 2020. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/development-andlicensure-vaccines-prevent-covid-19 (Consulted October 20, 2021).

3. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine;Baden;N Engl J Med,2021

4. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine;Polack;N Engl J Med,2020

5. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK;Voysey;Lancet,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3